膜性肾病中的补体激活与效应通路
本综述总结膜性肾病中补体激活与效应通路的研究证据,包括活检组织与尿液中补体产物检测、被动Heymann肾炎模型及基于人类相关靶抗原的动物和体外模型。补体在膜性肾病中起核心作用,靶向补体是潜在辅助治疗,但需针对特定补体通路进行个体化选择。
要点
- 补体激活是膜性肾病的核心特征,证据来自活检组织、尿液补体产物及机制研究。
- 即使B细胞清除有效,部分患者仍持续蛋白尿,可能与上皮下免疫复合物持续补体介导足细胞损伤有关。
- 靶向补体是膜性肾病有吸引力的辅助治疗,但需根据相关补体通路进行个体化选择。
核心结论
- 补体在膜性肾病中起核心作用,靶向补体是潜在辅助治疗但需针对特定补体通路个体化。
研究设计与样本
- 综述,汇总活检组织与尿液补体产物检测、被动Heymann肾炎模型及基于人类相关靶抗原的动物和体外模型证据。
主要发现
- 活检组织和尿液补体产物检测支持补体在膜性肾病中的作用。
- 被动Heymann肾炎模型提供了补体作用的机制证据。
- 基于人类相关靶抗原的动物和体外模型提供了补体激活与效应通路的更详细机制。
- 即使B细胞清除有效,部分患者仅达部分蛋白尿缓解,可能与上皮下免疫复合物持续及补体介导足细胞损伤有关。
临床怎么用
- 靶向补体可作为膜性肾病的辅助治疗,但需根据特定补体通路进行个体化选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Complement activation has long been recognized as a central feature of membranous nephropathy (MN). Evidence for its role has been derived from the detection of complement products in biopsy tissue and urine from patients with MN and from mechanistic studies primarily based on the passive Heymann nephritis model. Only recently, more detailed insights into the exact mechanisms of complement activation and effector pathways have been gained from patient data, animal models, and in vitro models based on specific target antigens relevant to the human disease. These data are of clinical relevance, as they parallel the recent development of numerous specific complement therapeutics for clinical use. Despite efficient B-cell depletion, many patients with MN achieve only partial remission of proteinuria, which may be explained by the persistence of subepithelial immune complexes and ongoing complement-mediated podocyte injury. Targeting complement, therefore, represents an attractive adjunct treatment for MN, but it will need to be tailored to the specific complement pathways relevant to MN. This review summarizes the different lines of evidence for a central role of complement in MN and for the relevance of distinct complement activation and effector pathways, with a focus on recent developments.
引用
- Kistler AD, Salant DJ. Complement activation and effector pathways in membranous nephropathy. Kidney Int. 2023. PMID: 38142037. doi:10.1016/j.kint.2023.10.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。